Invention Grant
- Patent Title: Antibodies, combinations comprising antibodies, biomarkers, uses and methods
-
Application No.: US16346675Application Date: 2017-11-03
-
Publication No.: US11779604B2Publication Date: 2023-10-10
- Inventor: Philip Bland-Ward , Leslie Kean , Victor Tkachev
- Applicant: Kymab Limited
- Applicant Address: GB Cambridge
- Assignee: KYMAB LIMITED
- Current Assignee: KYMAB LIMITED
- Current Assignee Address: GB Cambridge
- Agency: LATHROP GPM LLP
- Agent James H. Velema; Judith L. Stone-Hulslander
- Priority: GB 18529 2016.11.03 GB 02965 2017.02.23 GB 06639 2017.04.26 GB 10953 2017.07.07 GB 13147 2017.08.16
- International Application: PCT/EP2017/078202 2017.11.03
- International Announcement: WO2018/083248A 2018.05.11
- Date entered country: 2019-05-01
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; A61K35/17 ; A61P37/06 ; A61K31/436 ; C07K16/28 ; C12N5/0783 ; A61K45/06
Abstract:
The present invention relates to combinations comprising anti-human x OX40L antibodies, new biomarkers of autoimmune or alloimmune deseases, and their use in various therapeutic methods.
Public/Granted literature
- US20190275084A1 ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS Public/Granted day:2019-09-12
Information query
